With the successful completion of a second closing, Labforward adds more than three million Euro to the Series B from January, bringing the total funds raised to more than 8.5 million Euro. The majority of the new investment comes from the Fielmann Family Office, majority owner of the leading German family business of the same name that serves its 27 million customers across 15 European markets with eyewear and hearing aids.
Read on